CPT code 77021 denotes the imaging supervision and interpretation component of a separately reportable needle placement procedure performed under magnetic resonance guidance. Nationally, this code clarifies billing when the procedural act (biopsy or aspiration) is reported separately, ensuring that the imaging expert’s supervision and image interpretation are captured distinct from the interventional service. Accurate use of 77021 supports appropriate claims processing and clinical documentation for MR-guided procedures.

Key payers referenced in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of how 77021 is defined, common sites of service where it is applied, and which payers typically recognize the code. The publication summarizes benchmarking and reimbursement context where available, highlights relevant policy considerations affecting national coverage and billing, and outlines clinical scenarios that commonly generate use of 77021.

This executive summary aims to provide clinicians, coders, and billing professionals a focused national perspective on the purpose and application of CPT code 77021, what to expect in payer recognition, and where to look for further documentation and policy details. Data not available in the input is noted where applicable.